VaxCell-Bio wins global G-Rex Grant
VaxCell-Bio, a biotech company in Korea specializing in immunotherapies, has been awarded a $215,000 grant through the G-Rex Grant Program. This program, supported by leading global cell and gene therapy manufacturers such as ScaleReady, Wilson Wolf, and …